Breast cancer sentinel node metastases: Histopathologic detection and clinical significance

Cancer Control

Volumn 8, Issue 5, 2001, Pages 407-414

  Ollila, David W ^a   Stitzenberg, Karyn B ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; EOSIN; HEMATOXYLIN;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MICROSCOPIC ANATOMY; MORBIDITY; PATHOLOGICAL ANATOMY; PREDICTION; RELIABILITY; RISK FACTOR; SENTINEL LYMPH NODE; STAINING;

EID: 0034810184     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480100800503     Document Type: Article

References (47)

1. Technical details of intraoperative lymphatic mapping for early stage melanoma
2. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
3. Sentinel lymphadenectomy in breast cancer
4. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer
5. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
6. The sentinel node in breast cancer: A multicenter validation study
7. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye
8. Lymphatic mapping and sentinel lymphadenectomy: Critical review of technique
9. Obscure axillary lymph-node metastasis in carcinoma of the breast
10. Lymph node micrometastases from breast carcinoma: Reviewing the dilemma
11. Significance of occult metastases: A study of breast cancer
12. Predictors of nonsentinel node metastasis in breast cancer patients: Size and extracapsular extension of the sentinel node metastasis
13. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?
14. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node
15. Sentinel lymph node biopsy with metastasis: Can axillary dissection be avoided in some patients with breast cancer?
16. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes
17. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: Reevaluation with longer follow-up
18. Occult axillary node metastases in breast cancer: Their detection and prognostic significance
19. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: A multicenter study
20. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: A study to evaluate the need for complete axillary lymph node dissection
21. Sentinel lymphadenectomy: Immunohistologic validation and improved axillary staging for breast carcinoma: The Chapel Hill experience
22. Comparison of different histopathological methods for the examination of sentinel lymph nodes in breast cancer
23. Serial sectioning of sentinel nodes in patients with breast cancer: A pilot study
24. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma
25. Axillary sentinel lymph node examination in breast carcinoma
26. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study
27. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging
28. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: An NSABP update
29. Pathological prognostic factors in stage I (TlNOMO) and stage II (TINIMO) breast carcinoma: A study of 644 patients with median follow-up of 18 years
30. Occult axillary lymph node metastases in invasive breast carcinoma: Characteristics of the primary tumor and significance of the metastases
31. Importance of tumor cells in axillary node sinus margins ('clandestine' metastases) discovered by serial sectioning in operable breast carcinoma
32. Prognostic importance of occult axillary lymph node micrometastases from breast cancers
33. Detection and significance of occult metastases in node-negative breast cancer
34. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer
35. Axillary node micrometastases and breast cancer
36. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). V. Significance of axillary nodal micro- and macrometastases
37. Clinical significance of axillary micrometastases in breast cancer: How small is too small?
38. Protocol ACOSOG-ZOO10, GUMC-00152
39. Protocol NSABP B-32
40. Sentinel node metastasis with extracapsular extension can predict risk of nonsentinel node involvement in breast cancer patients (poster presentation)
41. Pathologic findings from the national surgical adjuvant breast project. (Protocol No. 4). III. The significance of extranodal extension of axillary metastases
42. Implications of extracapsular nodal metastases for treatment and prognosis of breast cancer
43. Significance of axillary lymph node extranodal soft tissue extension and indications for postmastectomy irradiation
44. The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy
45. Are axillary recurrence and overall survival affected by axillary extranodal tumor extension in breast cancer? Implications for radiation therapy
46. Carcinoma of the breast: The prognostic significance of extranodal extension of axillary disease
47. Protocol ACOSAG-20011, GUMC-00153